In RA, use of systemic glucocorticoids ≥5 mg/d (prednisolone-equivalent) was linked to MACE at 8.7 y.
Where this comes from
- Record sourced from PubMed, PMID 37931264.
- Also identified by DOI 10.7326/J23-0082.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
So H, Lam TO, Meng H, et al. <b>Time and dose-dependent effect of systemic glucocorticoids on major adverse cardiovascular event in patients with rheumatoid arthritis: a population-based study.</b> Ann Rheum Dis. 2023;82:1387-1393.37487608.
Medical subject headings
- Arthritis, Rheumatoid
- Antirheumatic Agents